Management and Prevention of Saphenous Vein Graft Failure: A Review

被引：77
作者：
McKavanagh P. [1 ]
Yanagawa B. [1 ]
Zawadowski G. [1 ]
Cheema A. [1 ]
机构：
[1] Terrence Donnelly Heart Center, Divisions of Cardiology and Cardiac Surgery, St Michael’s Hospital, University of Toronto, Toronto
来源：
Cardiology and Therapy | 2017年 / 6卷 / 2期
关键词：
Anticoagulation; Antiplatelet; Graft failure; Saphenous vein graft;
D O I：
10.1007/s40119-017-0094-6
中图分类号：
学科分类号：
摘要：
Coronary artery bypass grafting (CABG) remains a vital treatment for patients with multivessel coronary artery disease (CAD), especially diabetics. The long-term benefit of the internal thoracic artery graft is well established and remains the gold standard for revascularization of severe CAD. It is not always possible to achieve complete revascularization through arterial grafts, necessitating the use of saphenous vein grafts (SVG). Unfortunately, SVGs do not have the same longevity, and their failure is associated with significant adverse cardiac outcomes and mortality. This paper reviews the pathogenesis of SVG failure, highlighting the difference between early, intermediate, and late failure. It also addresses the different surgical techniques that affect the incidence of SVG failure, as well as the medical and percutaneous prevention and treatment options in contemporary practice. © 2017, The Author(s).
引用
收藏
页码：203 / 223
页数：20
相关论文
共 127 条
[1]  
Yusuf S., Zucker D., Peduzzi P., Fisher L.D., Takaro T., Kennedy J.W., Davis K., Killip T., Passamani E., Norris R., Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration, Lancet, 344, pp. 563-570, (1994)
[2]  
Davis K.B., Chaitman B., Ryan T., Bittner V., Kennedy J.W., Comparison of 15-year survival for men and women after initial medical or surgical treatment for coronary artery disease, J Am Coll Cardiol, 25, pp. 1000-1009, (1995)
[3]  
Banning A.P., Westaby S., Morice M.-C., Kappetein A.P., Mohr F.W., Berti S., Et al., Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents, J Am Coll Cardiol, 55, pp. 1067-1075, (2010)
[4]  
Dangas G.D., Farkouh M.E., Sleeper L.A., Yang M., Schoos M.M., Macaya C., Abizaid A., Buller C.E., Devlin G., Rodriguez A.E., Lansky A.J., Siami F.S., Domanski M., Fuster V., Long-term outcome of PCI versus CABG in insulin and non-insulin-treated diabetic patients: results from the FREEDOM trial, J Am Coll Cardiol, 64, 12, pp. 1189-1197, (2014)
[5]  
Frye R.L., August P., Brooks M.M., Hardison R.M., Kelsey S.F., MacGregor J.M., Orchard T.J., Chaitman B.R., Genuth S.M., Goldberg S.H., Hlatky M.A., Jones T.L., Molitch M.E., Nesto R.W., Sako E.Y., Sobel B.E., A randomized trial of therapies for type 2 diabetes and coronary artery disease, N Engl J Med, 360, 24, pp. 2503-2515, (2009)
[6]  
Roger V.L., Go A.S., Lloyd-Jones D.M., Et al., Executive summary: heart disease and stroke statistics—2012 update: a report from the American Heart Association, Circulation, 125, pp. 188-197, (2012)
[7]  
Greenland P., Knoll M.D., Stamler J., Et al., Major risk factors as antecedents of fatal and nonfatal coronary heart disease events, JAMA, 290, pp. 891-897, (2003)
[8]  
Campeau L., Enjalbert M., Lesperance J., Et al., The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation. A study 10 years after aortocoronary bypass surgery, N Engl J Med, 311, pp. 1329-1332, (1984)
[9]  
Loop F.D., Lytle B.W., Cosgrove D.M., Stewart R.W., Goormastic M., Williams G.W., Golding L.A., Gill C.C., Taylor P.C., Sheldon W.C., Et al., Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events, N Engl J Med, 314, 1, pp. 1-6, (1986)
[10]  
Fitzgibbon G.M., Kafka H.P., Leach A.J., Keon W.J., Hooper G.D., Burton J.R., Coronary bypass graft fate and patient outcome: angiographic follow-up of 5065 grafts related to survival and reoperation in 1388 patients during 25 years, J Am Coll Cardiol, 28, pp. 616-626, (1996)
12345678910